Company Directory / research

PrivateFor profitresearchParis, France
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Size
1-10 people: larger than 0% of companies with a size listed
Age
5 years old.
Reach
No web traffic ranking listed.
BiotechnologyPharmaceuticalTherapeutics
Funding, as listed
$77M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Corteria Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Corteria Pharmaceuticals may be growing as the company has made a significant leadership appointment by bringing on a new chairman, which often indicates a strategic move to strengthen the company's governance and oversight during expansion phases. This appointment could be a precursor to further growth initiatives or a response to ongoing positive developments within the company. Additionally, being mentioned in the context of biotech companies making a difference suggests that Corteria Pharmaceuticals is recognized in the industry, which could correlate with positive performance and growth.
Summaries written by the source dataset, not by us, and not checked.
research in France.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 88,142 companies in France and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.